Literature DB >> 27554622

The role of extended criteria donors in liver transplantation for nonalcoholic steatohepatitis.

Francesca M Dimou1, Hemalkumar B Mehta2, Deepak Adhikari2, Robert C Harland3, Taylor S Riall3, Yong-Fang Kuo2.   

Abstract

BACKGROUND: Nonalcoholic steatohepatitis is expected to become the leading indication for liver transplantation. Use of extended criteria donors (ECD) may help with donor allocation in these patients. The objective of this study was to determine the use of ECDs in patients with nonalcoholic steatohepatitis undergoing liver transplantation to stimulate a liver-specific predictive model for ECD use.
METHODS: The United Network for Organ Sharing database was used to identify patients undergoing liver transplantation for nonalcoholic steatohepatitis (2002-2014). Cox hazards models were created using (1) United Network for Organ Sharing ECD criteria (based on kidney allocation), (2) individual donor characteristics (age, sex, race, cause of death, body mass index, cold ischemic time), and (3) the Kidney Donor Profile Index (KDPI) to examine the effect of ECDs on mortality and graft failure.
RESULTS: A total of 4,387 patients underwent liver transplantation for nonalcoholic steatohepatitis; 1,359 (30.9%) patients received an ECD. Transplantation with ECD livers had comparable patient survival (hazard ratio [HR] 1.06, 95% confidence interval [CI] 0.91-1.23) between donor types but an increased risk of graft failure (HR 1.18, 95% CI 1.03-1.36) compared to standard donors. Individual characteristics did not affect patient survival or graft failure. A 10% increase in KDPI was associated with a 28% increase in patient mortality (HR 1.28, 95% CI 1.02-1.60) and 45% increase in graft failure (HR 1.45, 95% CI 1.18-1.80).
CONCLUSION: Based on the current United Network for Organ Sharing definition, ECDs in nonalcoholic steatohepatitis were associated with similar overall survival but increased risk of graft failure. Given the shortage of organs, creation of an easily calculated, liver-specific model similar to the KDPI may help risk stratify patients and improve organ allocation.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27554622      PMCID: PMC5412705          DOI: 10.1016/j.surg.2016.06.051

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  22 in total

1.  Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States.

Authors:  Anita Afzali; Kristin Berry; George N Ioannou
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

2.  The impact of obesity as determined by modified body mass index on long-term outcome after liver transplantation: Canadian single-center experience.

Authors:  T Tanaka; E L Renner; N Selzner; G Therapondos; L B Lilly
Journal:  Transplant Proc       Date:  2013 Jul-Aug       Impact factor: 1.066

3.  The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.

Authors:  Austin L Spitzer; Oliver B Lao; André A S Dick; Ramasamy Bakthavatsalam; Jeffrey B Halldorson; Matthew M Yeh; Melissa P Upton; Jorge D Reyes; James D Perkins
Journal:  Liver Transpl       Date:  2010-07       Impact factor: 5.799

4.  Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States.

Authors:  Satheesh Nair; Sumita Verma; Paul J Thuluvath
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

Review 5.  Nonalcoholic fatty liver disease: a systematic review.

Authors:  Mary E Rinella
Journal:  JAMA       Date:  2015-06-09       Impact factor: 56.272

6.  Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.

Authors:  Robert J Wong; Maria Aguilar; Ramsey Cheung; Ryan B Perumpail; Stephen A Harrison; Zobair M Younossi; Aijaz Ahmed
Journal:  Gastroenterology       Date:  2014-11-25       Impact factor: 22.682

7.  Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index.

Authors:  Esther L de Graaf; James Kench; Pamela Dilworth; Nicholas A Shackel; Simone I Strasser; David Joseph; Henry Pleass; Michael Crawford; Geoff W McCaughan; Deborah J Verran
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

Review 8.  Risk of extended criteria donors in hepatitis C virus-positive recipients.

Authors:  Marina Berenguer
Journal:  Liver Transpl       Date:  2008-10       Impact factor: 5.799

Review 9.  Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation.

Authors:  Yuval A Patel; Carl L Berg; Cynthia A Moylan
Journal:  Dig Dis Sci       Date:  2016-01-27       Impact factor: 3.199

10.  The impact of wait list body mass index changes on the outcome after liver transplantation.

Authors:  Lorenzo A Orci; Pietro Edoardo Majno; Thierry Berney; Philippe Morel; Gilles Mentha; Christian Toso
Journal:  Transpl Int       Date:  2012-12-01       Impact factor: 3.782

View more
  2 in total

1.  Predictors of patient survival following liver transplant in non-alcoholic steatohepatitis: A systematic review and meta-analysis.

Authors:  Adam Minich; Fakhar Ali Qazi Arisar; Noor-Ul Saba Shaikh; Leanne Herman; Amirhossein Azhie; Ani Orchanian-Cheff; Keyur Patel; Sareh Keshavarzi; Mamatha Bhat
Journal:  EClinicalMedicine       Date:  2022-07-01

Review 2.  Complement Activation in Liver Transplantation: Role of Donor Macrosteatosis and Implications in Delayed Graft Function.

Authors:  Kelley Núñez; Paul Thevenot; Abeer Alfadhli; Ari Cohen
Journal:  Int J Mol Sci       Date:  2018-06-13       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.